Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSUR.L Regulatory News (SUR)

  • There is currently no data for SUR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - SUR LN

19 Jun 2023 17:19

RNS Number : 2106D
Syquant Capital
19 June 2023
 

This form replaces RNS number 1618D which contained erroneous information in section 3(a)

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

SYQUANT CAPITAL

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Sureserve Group Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

June 16, 2023

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

10p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

3,372,025

2.02%

 

 

(2) Derivatives (other than options):

 

(3) Options and agreements to purchase/sell:

 

 

 

 

TOTAL:

3,372,025

2.02%

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

10p ordinary

Purchase

 

424,411

124 GBp

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

N/A

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

N/A

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

June 19, 2023

Contact name:

Laurent Boscherel

Telephone number:

+33 1 42 56 56 27

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETNKCBDABKDPAD
Date   Source Headline
4th Apr 202210:18 amRNSHolding(s) in Company
31st Mar 20227:00 amRNSExercise of Options and Total Voting Rights
22nd Mar 20221:31 pmRNSResult of AGM
22nd Mar 20221:14 pmRNSIssue of Equity and Total Voting Rights
15th Feb 20224:56 pmRNSAnnual Financial Report & Notice of AGM
1st Feb 20223:30 pmRNSExercise of Options and Total Voting Rights
1st Feb 20227:00 amRNS10-year £20 million win for Tower Hamlets Homes
25th Jan 20227:00 amRNSPreliminary Results
23rd Dec 20217:00 amRNSGrant of Options
16th Dec 20218:37 amRNSExercise of Options and Total Voting Rights
14th Dec 20217:00 amRNSAppointment of Interim CFO
9th Dec 20217:00 amRNSIssue of Shares and Total Voting Rights
8th Dec 20217:00 amRNSAcquisition of CorEnergy Limited
2nd Dec 20213:05 pmRNSChange of Registered Office
19th Nov 20214:01 pmRNSHolding(s) in Company
16th Nov 20217:00 amRNSHolding(s) in Company
4th Nov 20217:00 amRNSAppointment of Chief Executive Officer
7th Oct 202111:24 amRNSDirector/PDMR Shareholding
7th Oct 20217:00 amRNSTrading Update
20th Sep 20215:54 pmRNSExercise of Options and Total Voting Rights
23rd Aug 20217:00 amRNS10-year contract extension worth £140m
28th Jul 20212:27 pmRNSDirector/PDMR Shareholding
23rd Jul 20218:46 amRNSExercise of Options and Total Voting Rights
8th Jul 20218:45 amRNS8-year contract worth £36 million for PA Housing
18th Jun 20218:27 amRNSExercise of Options and Total Voting Rights
7th Jun 202111:27 amRNSTransaction by Director/PDMR
7th Jun 20217:00 amRNSExercise of Options and Total Voting Rights
26th May 20217:00 amRNSAppointment of Chairman
20th May 20215:49 pmRNSHolding(s) in Company
19th May 20215:07 pmRNSHolding(s) in Company
18th May 20217:00 amRNSInterim Results
26th Apr 202111:21 amRNSExercise of Options and Total Voting Rights
16th Apr 20213:42 pmRNSHolding(s) in Company
15th Apr 202112:00 pmRNSDirector/PDMR Shareholding
12th Apr 20213:40 pmRNSNotice of Interim Results
12th Apr 20217:00 amRNSExercise of Options and Total Voting Rights
6th Apr 202111:00 amRNSExercise of Options and Total Voting Rights
30th Mar 20214:35 pmRNSTransaction by Director/PDMR
30th Mar 20211:44 pmRNSTransaction by Director/PDMR
18th Mar 202112:30 pmRNSResult of AGM
18th Mar 202111:06 amRNSSecond Price Monitoring Extn
18th Mar 202111:01 amRNSPrice Monitoring Extension
18th Mar 20219:05 amRNSSecond Price Monitoring Extn
18th Mar 20219:00 amRNSPrice Monitoring Extension
18th Mar 20217:00 amRNSDirectorate Change
1st Mar 20217:06 amRNSTotal Voting Rights
19th Feb 20217:00 amRNSPosting of Accounts and AGM
12th Feb 20213:30 pmRNSHolding(s) in Company
8th Feb 20217:00 amRNSHolding(s) in Company
2nd Feb 20217:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.